| CORCEPT THERAPEUTICS INC. |
| USA |
| Gesundheit |
| US2183521028 / 529882 |
| HTD (Frankfurt) / CORT (NASDAQ) |
| FRA:HTD, ETR:HTD, HTD:GR, NASDAQ:CORT |
| - |
| https://www.corcept.com/ |
|
Corcept Therapeutics Incorporated is a pharmaceutical company specializing in the research, development, and commercialization of innovative therapies that modulate cortisol activity. With over 25 yea..
>Volltext.. |
| 3553.41 Mio. EUR |
| 3198.94 Mio. EUR |
| 626.42 Mio. EUR |
| 57 Mio. EUR |
| 88.44 Mio. EUR |
| 0.85 EUR |
| 5.37 Mio. EUR |
| 105.76 Mio. EUR |
| 137.63 Mio. EUR |
| 2.45 |
| 11.88% |
| -29.31% |
| - |
| - |
| - |
| CORCEPT THERAPEUTICS, CORCEPT THERAPEUTIC |
| 19.02.26 |